Search for: "Janssen v. Janssen" Results 281 - 300 of 385
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Mar 2011, 5:02 am by Brian A. Comer
“After the judge makes a determination as to damages, we will consider our options,” Panico said in his statement.The case is State of South Carolina v. [read post]
22 Mar 2011, 5:08 am by Brian A. Comer
Risperdal is different from other antipsychotic medicines and “doctors needed to know that,” he added.Jurors will begin deliberating the case tomorrow.The case is State of South Carolina v. [read post]
24 Feb 2011, 1:49 pm by Bexis
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
25 Jan 2011, 10:58 pm by Marie Louise
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
11 Jan 2011, 11:07 pm by Kelly
Supreme Court to take on patent settlement agreements: Louisiana Wholesale Drug Co et al v Bayer et al (FDA Law Blog) US: BIO joins 170 business, research institutions and organisations to urge caution in Microsoft v i4i case (PatentlyBIOtech) US: Galderma wins important victory in fight against Leo’s psoriasis patent covering vitamin D, corticosteroid composition for ‘dermal use’ (Reexamination Alert) US: Déjà vu! [read post]
15 Dec 2010, 2:17 am by Kelly
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not patentable… [read post]
21 Jul 2010, 9:49 pm by Aaron Barkoff
Forest (where the Federal Circuit held that blocking a generic drug company from selling a noninfringing product presents a justiciable controversy) than in Janssen v. [read post]
13 May 2010, 12:27 pm by Bexis
Janssen Pharmaceutica, Inc., 288 Fed. [read post]